General Information of Drug Inactive Ingredient (DIG) (ID: E00115)

DIG Name
Propane
Synonyms
PROPANE; n-Propane; Dimethylmethane; propan; Propyl hydride; 74-98-6; Hydrocarbon Propellant A-108; A-108; HC 290; UNII-T75W9911L6; R 290; E944; CH3-CH2-CH3; CHEBI:32879; T75W9911L6; Propyldihydride; Praseodymium doped ceria; Propane liquefied; cerium oxide, praseodymium doped; Hydrocarbons, C6-30; Alkanes, C18-70; Petroleum gas, liquefied; Hydrocarbons, C<10-linear; 130071-47-5; Propane-1,1,1,2,3,3,3-d7; Hydrocarbons, C2-4, C3-rich; HSDB 1672; Propane, propylene mix; Propane [USAN:NF]; C18-70 Isoparaffin; EINECS 200-827-9; UN1978; (C18-C70) Paraffins; Splitter butane; C3H8; C3 hydrocarbons; Propylidyneradical; n-Propane-; EINECS 270-689-2; EINECS 272-913-4; EINECS 274-000-6; EINECS 275-017-1; Propane (NF); Praseodymium Nanofoil; Propane, propylene after caustic wash; 344239-80-1; Propane, 98%; Freon 290; Praseodymium Nanoparticles; Propane, 99.97%; Propane, propene fraction; Aliph. hydrocarbons, C3; PROPANE-1-D1; EC 200-827-9; EC 270-689-2; Polymeric sialosie, P0.1; Propane or propane mixtures; [C]CC; FCC Propane-propylene stream; 68476-49-3; 68920-07-0; 69430-33-7; 70913-86-9; CHEMBL135416; QSPL 135; Propane, tank for propane torch; DTXSID5026386; PROPANE-1,1,1-D3; Ultra Thin Praseodymium Nanofoil; Hydrocarbons, C7-C8, n-alkanes; [C][CH][CH2]; DTXSID501019643; Hydrocarbons, C3 and C3-unsatd.; AMY22280; EINECS 271-259-7; EINECS 271-735-4; C([C])[C]; CF0048; AKOS009159189; Mixed (C1-C3) gases from debutanizer; PROPANE-1,1,1,2,2-D5; UN 1978; Propane, 99.95%, Messer(R) CANGas; PROPANE-1,1,1,2,2,3-D6; 427-EP2270895A2; 427-EP2275417A2; 427-EP2277861A1; 427-EP2278637A1; 427-EP2281812A1; 427-EP2281819A1; 427-EP2281821A1; 427-EP2284162A2; 427-EP2284163A2; 427-EP2292630A1; 427-EP2295438A1; 427-EP2295503A1; 427-EP2301918A1; 427-EP2305243A1; 427-EP2305683A1; 427-EP2305687A1; 427-EP2311806A2; 427-EP2311839A1; 427-EP2314589A1; 427-EP2316470A2; 427-EP2316837A1; 427-EP2377845A1; 427-EP2380568A1; 427-EP2380661A2; PROPANE-1,1,1,2,2,3,3-D7; C20783; D05625; EC 271-735-4; 28680-EP2279741A2; 28680-EP2308843A1; 28680-EP2314579A1; 29038-EP2305644A1; 29038-EP2311842A2; 78036-EP2272846A1; 78036-EP2277868A1; 78036-EP2277869A1; 78036-EP2277870A1; 78036-EP2292608A1; 78036-EP2298076A1; 78036-EP2298077A1; 78036-EP2301353A1; 78036-EP2305031A1; 78036-EP2305034A1; 78036-EP2305035A1; 78036-EP2308866A1; Q131189; Molybdenum Aluminium (Mo-Al) Alloy Sputtering Targets; Propane-propylene from catalytic cracking (petroleum); Propane or propane mixtures [UN1978] [Flammable gas]; 1DDB43B7-5E0D-48E4-8F15-3D3D5116098A; UNII-5K616HU99V component ATUOYWHBWRKTHZ-UHFFFAOYSA-N; 1174921-63-1; 20717-73-1; 2875-97-0; 349553-90-8; 358731-98-3; 7371-42-8; 97565-91-8
DIG Function
Aerosol propellant
Formula
C3H8
Canonical SMILES
CCC
InChI
1S/C3H8/c1-3-2/h3H2,1-2H3
InChIKey
ATUOYWHBWRKTHZ-UHFFFAOYSA-N
Physicochemical Properties Molecular Weight 44.1 Topological Polar Surface Area 0
XlogP 1.8 Complexity 0
Heavy Atom Count 3 Rotatable Bond Count 0
Hydrogen Bond Donor Count 0 Hydrogen Bond Acceptor Count 0

Full List of Drug(s) Co-administrated with This DIG

1 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Betamethasone DMAHJEF Acute adrenal insufficiency [] Betamethasone Valerate 0.12% aerosol F23643
------------------
1 Clinical Trial Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Impoyz DMB1N6P Scalp dermatosis [] Clobetasol Propionate 0.05% aerosol F23047
------------------